Skip to content

Ayurveda treatment in the managment of Vrikka Vikar (Chronic Kidney Disease).

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF AYURVEDIC TRIAL INTERVENTION IN THE MANAGEMENT OF VRIKKA VIKAR WITH SPECIAL REFERENCE TO CHRONIC KIDNEY DISEASE (CKD) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081816
Enrollment
30
Registered
2025-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

None listed

Sponsors

NATIONAL INSTITUTE OF AYURVEDA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with GFR level less than 60 ml /min / 1.73 m2 and persistent (present for more than 3 months. Patients of Serum creatinine level between 1.2 to 6.5 mg/dl Potassium level more than 5.5 mmol/L Patients of blood urea level between 48 to 180 mg/dl. Patients with Haemoglogin more than equal to 7gm/dl Patients with blood pressure less than equal to 160/100 mm of Hg. Patients having any clinical sings and symptoms of chronic kidney disease.

Exclusion criteria

Exclusion criteria: Patients with eGFR less than 15 mL/min/1.73m2 or on dialysis. Patients having other associated disease like congenital disease Myeloma, Neoplasm etc. Pregnant or lactating women. Faimilial or hereditary kidney disease e.g. polycystic kidney. Patients having some serious illness like cardio-vascular disease, acute mental disorders, serious chronic co-morbidity, hypo or hyper thyroidism, liver or metabolic disorders etc.

Design outcomes

Primary

MeasureTime frame
Change in renal function test from baseline value at the end of the tiral. Timepoint: At baseline and after four weeks

Secondary

MeasureTime frame
Secondary outcome - change in urine output level from baseline value at the end of trial. change in symptoms of CKD from baseline value at the end of trial.Timepoint: After four weeks

Countries

India

Contacts

Public ContactDr Harish Bhakuni

NATIONAL INSTITUTE OF AYURVEDA

harishbhakuni78@gmail.com7891233108

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026